Physician profile
Chad S Smith
NPI 1679675334
$1,029.49
in general payments reported to CMS, 2019-2025
13 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $141 · 2022: $22.01 · 2024: $362 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $258.98 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $175.65 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $121.77 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Kala Pharmaceuticals, INC. | $106.22 | 2020 | |
| Thea Pharma INC. | $84.75 | 2024 | Iyuzeh |
| Amgen INC. | $83.07 | 2024-2025 | Tepezza |
| Oyster Point Pharma, INC. | $51.99 | 2024 | Ryzumvi, Tyrvaya |
| Dompe US, INC. | $45.92 | 2024-2025 | Oxervate |
| Biotissue Holdings INC. | $24.20 | 2024 | |
| Genzyme Corporation | $22.01 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $20.72 | 2024 | Tecnis Simplicity |
| Novartis Pharmaceuticals Corporation | $18.35 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.